India to Canada: Leflunomide Export Trade Route

The India to Canada Leflunomide corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $574.8K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 83% of all export value, reflecting the consolidated nature of India's leflunomide manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $26.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with leflunomide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #20 among India's top leflunomide export destinations globally.

On the import side, key buyers of Indian leflunomide in Canada include ROPACK, ROPACK , ROPACK RUE MIRABEAU. ROPACK is the single largest importer with 17 shipments valued at $411.4K USD.

India's leflunomide exports to Canada are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $26.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as leflunomide tablet 20mg pac size 1x40000x2 335 pac 93400 nos and leflunomide tablet 20mg [pac size:1x40000x2.307 pac=92280 nos], suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ROPACK is the largest importer with 17 shipments worth $411.4K USD — representing 72% of all leflunomide imports from India on this route.